miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study. Gagez AL, Duroux-Richard I, Leprêtre S, Orsini-Piocelle F, Letestu R, De Guibert S, Tuaillon E, Leblond V, Khalifa O, Gouilleux-Gruart V, Banos A, Tournilhac O, Dupuis J, Jorgensen C, Cartron G, Apparailly F. Haematologica. 2017 Apr;102(4):746-754.

Differential morphological and functional features of fibroblasts explanted from Solar Lentigo. Goorochurn R, Viennet C, Tissot M, Locatelli F, Granger C, Varin-Blank N, Humbert P, Le Roy C. Br J Dermatol. 2017 Feb 17.

Phosphorylation impact on Spleen Tyrosine kinase conformation by Surface Enhanced Raman Spectroscopy. Cottat M, Yasukuni R, Homma Y, Lidgi-Guigui N, Varin-Blank N, Lamy de la Chapelle M, Le Roy C. Sci Rep. 2017 Jan 5;7:39766.

Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL. Barr PM, Brown JR, Hillmen P, O'Brien S, Barrientos JC, Reddy NM, Coutre S, Mulligan SP, Jaeger U,Furman RR, Cymbalista F, Montillo M, Dearden C, Robak T, Moreno C, Pagel JM, Burger JA, Suzuki S, Sukbuntherng J, Cole G, James DF, Byrd JC. Blood. 2017 Apr 3.

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice. Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N, Donehower LA, El-Deiry WS, Fenaux P, Gaidano G, Langerød A, Hellstrom-Lindberg E, Iggo R, Lehmann-Che J, Mai PL, Malkin D, MollUM, Myers JN, Nichols KE, Pospisilova S, Ashton-Prolla P, Rossi D, Savage SA, Strong LC, Tonin PN, Zeillinger R, Zenz T, Fraumeni JF Jr, Taschner PE, Hainaut P, Soussi T. Cancer Res. 2017 Mar 15;77(6):1250-1260.

Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-worldexperience of 71 patients treated in France A study from the French Innovative Leukemia Organization (FILO) group. Michallet AS, Campidelli A, Lequeu H, Dilhuydy MS, Tournilhac O, Fornecker LM, Dupuis J, Cymbalista F, De Guibert S, Delmer A, Vilque JP, Ghez D, Leblond V, Subtil F, Feugier P, Ysebaert L. Am J Hematol. 2017 Mar 10.

Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study. Montillo M, O'Brien S, Tedeschi A, Byrd JC, Dearden C, Gill D, Brown JR, Barrientos JC, Mulligan SP,Furman RR, Cymbalista F, Plascencia C, Chang S, Hsu E, James DF, Hillmen P. Blood Cancer J. 2017 Feb 3;7(2):e524.

Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients. Wanquet A, Birsen R, Bonnet C, Boubaya M, Choquet S, Dupuis J, Lepretre S, Re D, Fahri J, Michallet AS, Ysebaert L, Lemal R, Lamy T, Delarue R, Troussard X, Cymbalista F, Levy V, Dietrich PY, Leblond V, Aurran-Schleinitz T. Br J Haematol. 2017 Jan;176(1):37-49